首页 正文

Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date

{{output}}
Psoriasis is a common chronic immune-mediated skin disease, with systemic involvement and significant impact in patients' quality of life. Several highly specific treatments have been developed over the years, such as tumor necrosis factor-α inhibitors, a non... ...